American College of Cardiology

FEBRUARY 12, 2024

The MULTISTARS AMI (MULTivessel Immediate versus STAged RevaScularization in Acute Myocardial Infarction) trial compared immediate versus delayed percutaneous coronary intervention (PCI) of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) who underwent successful primary PCI of the culprit lesion.

Myocardial Infarction 64

Myocardial Infarction STEMI Article 64

American College of Cardiology

NOVEMBER 7, 2024

What is the impact of complete revascularization versus culprit-only revascularization on outcomes in older patients with ST-segment elevation myocardial infarction (STEMI) and non–ST-segment elevation myocardial infarction (NSTEMI)?

STEMI 68

STEMI Myocardial Infarction Outcomes Article 68

American College of Cardiology

NOVEMBER 17, 2024

The goal of the CLEAR SYNERGY (OASIS 9) spironolactone trial was to determine the potential cardiovascular (CV) benefit of spironolactone following percutaneous coronary intervention (PCI) for ST-segment or large non–ST-segment elevation myocardial infarction (STEMI or NSTEMI, respectively) regardless of post-MI left ventricular ejection fraction (..)

Myocardial Infarction 58

Myocardial Infarction STEMI Article 58

Med Page Today

OCTOBER 29, 2024

(MedPage Today) -- The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to findings from the Chinese.

Heart Attack 111

Heart Attack Heart attacks Myocardial Infarction STEMI 111

Dr. Smith's ECG Blog

MAY 27, 2024

The ECG did not meet STEMI criteria, and the final cardiology interpretation was “ST and T wave abnormality, consider anterior ischemia”. There’s only minimal ST elevation in III, which does not meet STEMI criteria of 1mm in two contiguous leads. But STEMI criteria is only 43% sensitive for OMI.[1]

Chest Pain 128

Chest Pain STEMI Myocardial Infarction Ischemia 128

Journal of Cardiothoracic Surgery

MARCH 29, 2024

Accurately predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) remains a complex and critic.

Myocardial Infarction 52

Myocardial Infarction STEMI Research 52

American College of Cardiology

SEPTEMBER 18, 2024

What are long-term clinical benefits of complete versus culprit-only revascularization among ST-segment elevation myocardial infarction (STEMI) patients aged ≥75 years?

STEMI 58

STEMI Myocardial Infarction Article 58

American College of Cardiology

JUNE 21, 2024

What is the safety and effectiveness of P2Y12 inhibitor pretreatment in patients transferred for primary percutaneous coronary intervention (PPCI) within a regional ST-segment elevation myocardial infarction (STEMI) network?

STEMI 60

STEMI Myocardial Infarction Article 60

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction Differences in pathophysiology, clinical presentation, and natural course of ST-elevation myocardial infarction in female patients due to either spontaneous dissection (SCAD-STEMI) or atherothrombotic occlusion (type 1 STEMI) have been discussed. vs. 1.8 ± 5.1%, p  = 0.002). vs. 1.8 ± 5.1%, p  = 0.002).

Myocardial Infarction 59

Myocardial Infarction SCAD STEMI Thrombolysis 59

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

Background Despite the crucial role of Chest pain centers (CPCs) in acute myocardial infarction (AMI) management, China's mortality rate for ST-segment elevation myocardial infarction (STEMI) has remained stagnant. Conclusion CPC quality control metrics affect STEMI mortality based on Killip class.

Myocardial Infarction 59

Myocardial Infarction Chest Pain COVID-19 Catheterization Laboratory 59

Frontiers in Cardiovascular Medicine

JULY 22, 2024

IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardial infarction (STEMI). Patients were followed up for 4.5 years (±10.9), predominantly male (89.9%).

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

American College of Cardiology

OCTOBER 9, 2024

What are the outcomes of bivalirudin vs. heparin anticoagulation during percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI)?

STEMI 53

STEMI Myocardial Infarction Outcomes Article 53

All About Cardiovascular System and Disorders

FEBRUARY 6, 2024

STEMI – Anterior Wall ECG shows ST elevation myocardial infarction of anterior wall. Up sloping elevation of ST segment is seen in leads V1 to V5, with maximum ST elevation in V2, as is characteristic of anterior wall infarction. QS complexes are seen from V1 to V3.

STEMI 52

STEMI Myocardial Infarction Aneurysm Electrophysiology 52

Frontiers in Cardiovascular Medicine

DECEMBER 3, 2024

However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.ObjectiveTo explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction (STEMI).MethodsA

Myocardial Infarction 52

Myocardial Infarction STEMI Risk Factors Hospital 52

Frontiers in Cardiovascular Medicine

MARCH 10, 2024

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients.

Myocardial Infarction 59

Myocardial Infarction Cardiogenic Shock Outcomes Article 59

Heart BMJ

OCTOBER 10, 2024

Introduction ST-segment elevation myocardial infarction (STEMI) diagnosis is based on a clinical presentation and ST-segment elevation (STE) in at least two consecutive leads. 1 This paradox stems from the incorporation bias and feedback sanction bias detailed in subsequent paragraphs.

STEMI 52

STEMI Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

BackgroundAcute myocardial infarction (AMI), particularly ST-segment elevation myocardial infarction (STEMI), significantly impacts global health, exacerbated by risk factors such as diabetes mellitus (DM).

STEMI 52

STEMI Myocardial Infarction Risk Factors Diabetes 52

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Early ventricular tachycardia/fibrillation (VT/VF) in patients with ST-elevation myocardial infarction (STEMI) has higher morbidity and mortality. This study examines gender-differentiated risk factors and underlying mechanisms for early onset VT/VF in STEMI. vs. 61.0 ± 13.0 vs. 1.70 ± 0.28, P  = 0.02

Myocardial Infarction 59

Myocardial Infarction STEMI Defibrillator Diet 59

Open Heart

JANUARY 29, 2024

Objectives This study aimed to perform a meta-analysis of the short-term impact of ischaemic postconditioning (IPoC) on myocardial injury in ST elevation myocardial infarction (STEMI) using surrogate cardiac biomarkers. These results resonate with some studies using imaging techniques to ascertain myocardial damage.

Myocardial Infarction 52

Myocardial Infarction STEMI Article Biomarkers 52

Open Heart

JANUARY 27, 2022

Background Early recognition of ST-segment elevation myocardial infarction (STEMI) is needed for timely cardiac monitoring and reperfusion therapy. Results Of 5465 patients with STEMI, 73% were transported to hospital by ambulance. and non-ACS diagnosis in 29.7%.

Myocardial Infarction 52

Myocardial Infarction STEMI Hospital 52

Coronary Artery Disease Journal

OCTOBER 30, 2023

Introduction Elevated peak cardiac troponin levels have been linked with increased morbidity and mortality in patients with acute myocardial infarction (AMI). Results Among the 277 patients diagnosed with AMI who underwent IPF testing, 113 had (STEMI) and 164 had (NSTEMI). Notably, among STEMI patients, those with IPF ≥ 4.2%

Myocardial Infarction 52

Myocardial Infarction STEMI 52

Dr. Smith's ECG Blog

MAY 31, 2023

Cath lab declined as it is not a STEMI." And now this finding is even formally endorsed as a "STEMI equivalent" in the 2022 ACC guidelines!!! Another myocardial wall is sacrificed at the altar of the STEMI/NonSTEMI mindset. Opiates are associated with worse outcomes in Myocardial Infarction. Abstract 556.

STEMI 87

STEMI Chest Pain Myocardial Infarction Ischemia 87

Frontiers in Cardiovascular Medicine

OCTOBER 9, 2024

We developed a user-friendly web application for real-world use, yielding risk scores as a percentage.ConclusionsThe STEMI-ML score effectively predicts in-hospital outcomes in STEMI patients and may assist with risk stratification and individualising patient management.

STEMI 52

STEMI Hospital ICU Outcomes 52

Heart BMJ

JULY 10, 2024

Background Despite restoration of epicardial blood flow in acute ST-elevation myocardial infarction (STEMI), inadequate microcirculatory perfusion is common and portends a poor prognosis. Methods Comprehensive literature search of six electronic databases identified relevant randomised controlled trials.

Myocardial Infarction 52

Myocardial Infarction Thrombolysis STEMI Outcomes 52

Frontiers in Cardiovascular Medicine

DECEMBER 11, 2024

Background and objectivesThe optimal timing for complete revascularization (CR) in patients with acute myocardial infarction (AMI) and multivessel disease (MVD) remain uncertain.MethodsThis post-hoc analysis of the FRAME-AMI trial included AMI patients with MVD (n=549). Other secondary endpoints were also not significantly different.

Myocardial Infarction 40

Myocardial Infarction STEMI Outcomes Hospital 40

Open Heart

JANUARY 27, 2023

Background ST elevation myocardial infarction (STEMI) represents a cardiac emergency. Inferior STEMI represents a dilemma for cardiologists. Methods We performed a single-centre retrospective cohort analysis of all patients admitted to our hospital from 2008 to 2020 with a diagnosis of inferior STEMI.

STEMI 52

STEMI Myocardial Infarction Hospital 52

American College of Cardiology

JUNE 5, 2024

What is the impact of the administration of cangrelor at reperfusion on myocardial infarct (MI) size and microvascular obstruction (MVO) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI)?

STEMI 45

STEMI Myocardial Infarction Article 45

Dr. Smith's ECG Blog

SEPTEMBER 26, 2023

See these 2 articles Association between pre-hospital chest pain severity and myocardial injury in ST elevation myocardial infarction: A post-hoc analysis of the AVOID study Author links open overlay panel [link] 1 Background We sought to determine if an association exists between prehospital chest pain severity and markers of myocardial injury.

Chest Pain 119

Chest Pain STEMI Myocardial Infarction Hospital 119

American College of Cardiology

APRIL 7, 2024

The goal of the DanGer Shock trial was to compare the safety and efficacy of Impella CP on top of standard care compared with standard care alone among patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock.

Cardiogenic Shock 74

Cardiogenic Shock Myocardial Infarction STEMI Article 74

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.

Public Health 52

Public Health Myocardial Infarction STEMI Coronary Artery Disease 52

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Myocardial Infarction 40

Myocardial Infarction STEMI Research 40

American College of Cardiology

OCTOBER 28, 2024

The goal of the HELP-PCI trial was to determine the efficacy and safety of administering unfractionated heparin at first medical contact versus during cardiac catheterization only in patients with ST-segment elevation myocardial infarction (STEMI).

STEMI 49

STEMI Myocardial Infarction Article 49

Dr. S. Venkatesan MD

DECEMBER 29, 2023

Cardiogenic shock (CS)is the most feared event following STEMI. We tend to perceive CS as an exclusive complication of STEMI. The incidence is half of that of STEMI, i.e., 2.5-5%. might show little elevation with considerable overlap of left main STEMI vs NSTEMI ) 2.Onset ACS pathophysiology is not that simple.

Cardiogenic Shock 52

Cardiogenic Shock STEMI Myocardial Infarction Outcomes 52

Open Heart

AUGUST 17, 2023

Background Tocilizumab improves myocardial salvage index (MSI) in patients with ST-elevation myocardial infarction (STEMI), but its mechanisms of action are unclear. Methods STEMI patients were randomised to receive a single dose of 280 mg tocilizumab (n=101) or placebo (n=98) before percutaneous coronary intervention.

Myocardial Infarction 52

Myocardial Infarction STEMI 52

Open Heart

JUNE 21, 2022

Background Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Artery Disease Outcomes 52

Cardiovascular Diabetology

DECEMBER 5, 2023

Stress hyperglycemia ratio (SHR), associated with adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), has several definitions. This study aims to assess the prognostic value o.

Myocardial Infarction 45

Myocardial Infarction STEMI Outcomes Research 45

Open Heart

DECEMBER 7, 2023

Introduction Cardiogenic shock (CS) complicates 5%–15% of cases of acute myocardial infarction (AMI) with inpatient mortality greater than 40%. This prospective registry includes all patients >18 years of age presenting with STEMI with or without CS beginning on 1 February 2023.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction STEMI Heart Attack 52